BLUEBIRD VENTURES GP I, LLC

BLUEBIRD VENTURES GP I, LLC is a Seed, Series A, Series B and Series C+ fund in the US and Europe writing $100K–$5M checks into AI, Enterprise, Fintech, Healthcare, life-science, therapeutics, diagnostics, genomics, gene-therapy, rna-therapeutics and medical-devices.

Stages: Seed, Series A, Series B, Series C+
Sectors: AI, Enterprise, Fintech, Healthcare, life-science, therapeutics, diagnostics, genomics, gene-therapy, rna-therapeutics, medical-devices
Check size: $100K–$5M
Invests in: US-wide, Europe
Actively investing: Yes
Founded: 2019
Assets under management: $103.5M
Website: bluebirdvc.com

Thesis

Bluebird Ventures, founded in 2019, is a venture capital firm based in Palo Alto, California, that invests in early-stage life science and technology companies across North America and Europe. The firm targets companies developing therapeutics, diagnostics, genomics, gene therapy, RNA therapeutics, and medical devices. They also invest in technology companies with high growth potential and transformative business models in AI, FinTech, and SaaS. In 2019, Bluebird Ventures raised $103.5 million for a venture-capital fund.

Common questions

Does BLUEBIRD VENTURES GP I, LLC invest at the Seed stage?

Yes. BLUEBIRD VENTURES GP I, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.

What check size does BLUEBIRD VENTURES GP I, LLC write?

BLUEBIRD VENTURES GP I, LLC writes $100K–$5M checks.

Where does BLUEBIRD VENTURES GP I, LLC invest?

BLUEBIRD VENTURES GP I, LLC invests in the US and Europe.